S1PR4 and Psoriasiform dermatitis: For S1PR4, Schuster et al. [72] reported that imiquimod-induced psoriatic skin lesions created in S1pr4-deficient mice reduce the severity of psoriasiform dermatitis, decrease CCL2, IL-6, and CXCL1, and reduce infiltrating monocytes and granulocytes.